fda warning bpc 157 not approved 2024 2025 FDA's Overreach on Compounded Peptides The FDA is reviewing which

BPC-157 works best for soft tissue injuries where enhanced blood flow, collagen production, and cell migration can meaningfully accelerate natural healing

di Giancamillo A, Vitari F, Bosi G, Savoini G, Domeneghini C

Some peptides may show diminished effectiveness over time, necessitating dose adjustments or alternative treatment approaches

it contains no active drug

Practical Interpretation The mechanistic plausibility (NNMT NAD SIRT1/PGC-1 BMR & fat oxidation) is strong and consistent across preclinical models

BPC-157 is a synthetic 15-amino-acid peptide fragment originally isolated from human gastric juice, where it occurs as part of a larger body-protective protein